Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

Abbott has entered a global partnership focusing on the integration of its advanced FreeStyle Libre continuous glucose ...

Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

What makes an outstanding dividend stock? High yields can seem attractive to income seekers, but unless a company has a steady, reliable business, payout cuts are a real possibility no matter how ...

HYDERABAD Feb 25 (Reuters) - Medical device maker Medtronic (MDT.N), opens new tab is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U ...

Medtronic and Abbott Labs have raised their ... one of the leading franchises of continuous glucose monitoring (CGM) systems on the market. Abbott's management pointed out that the FreeStyle ...

with Medtronic offering $738 million for the business, saying it would combine EOFlow’s tubeless, wearable, and fully disposable EOPatch with its continuous glucose monitor (CGM) devices and ...

Medtronic plc MDT reported adjusted earnings ... with an increase in the MiniMed 780G installed base and strong CGM (continuous glucose monitoring) attachment rates. International revenues ...

one is Abbott Laboratories with its FreeStyle Libre CGM and the other is Medtronic. DXCM being the market leader in the industry with ~ billion revenue coming from CGM sales, Abbott and Medtronic ...